Close Icon
 
Scheduled maintenance work on Thursday 19th January 2016 between 00:00 and 06:00 hours (GMT)
One of our internet service providers will be performing maintenance upgrade work on their network which means you may experience an intermittent reduction in performance, with the possibility of our publishing platform services being offline temporarily. If you have any questions, please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.

MedChemComm

Research and review articles in medicinal chemistry and related drug discovery science; the official journal of the European Federation for Medicinal Chemistry

Review Article

Development of second generation epigenetic agents

*
Corresponding authors
a
Institute for Applied Cancer Sciences, MD Anderson Cancer Center, 1901 East Road, Room 4SCR6.1037, Houston, USA
E-mail: pjones3@mdanderson.org
Tel: +1 713 792 6371
Med. Chem. Commun., 2012,3, 135-161

DOI: 10.1039/C1MD00199J
Received 01 Aug 2011, Accepted 17 Sep 2011
First published online 26 Oct 2011

This article is part of themed collection: Epigenetics
Please wait while Download options loads